Frazier Management LLC Kezar Life Sciences, Inc. Transaction History

Frazier Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$2.77 - $5.75 $250,901 - $520,823	-90,578 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$2.5 - $4.26 $942,912 - $1.61 Million	-377,165 Reduced 80.64%	90,578 $363,000
Q2 2019 Aug 14, 2019	BUY	$7.09 - $21.9 $692,423 - $2.14 Million	97,662 Added 26.39%	467,743 $3.61 Million
Q1 2019 May 15, 2019	BUY	$16.83 - $23.75 $2.02 Million - $2.85 Million	120,081 Added 48.03%	370,081 $6.57 Million
Q2 2018 Aug 15, 2018	BUY	$17.15 - $17.79 $4.29 Million - $4.45 Million	250,000 New	250,000 $4.33 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.